HCV/INF: Your speculation assumes that "hyperdrive" is key. The scientific community does not even know yet if the virus is completely eradicated or simply held in check at an undetectable assay level. (I believe it is eradicated, but, that is irrelevant for this exercise.)
Additionally, how would you account for the non-IFN drugs working as a monotherapy? That isn't exactly the same immune system hyperdrive achieved via INF, eh?
From another angle, if a drug combo completely eradicates a virus, why would the immune system need to fight afterwards?
Market Data 
Markets 
AI
